Literature DB >> 2079717

Cortical glucose metabolism in Parkinson's and Alzheimer's disease.

R F Peppard1, W R Martin, C M Clark, G D Carr, P L McGeer, D B Calne.   

Abstract

Characteristic regional patterns of decreased cerebral glucose metabolism (rCMRG) have been described in a variety of neurodegenerative conditions associated with dementia. The present study was undertaken to determine whether the metabolic pattern in Parkinson's disease is altered by the presence of impaired cognitive function. Glucose metabolism was measured with positron emission tomography in 6 patients with Parkinson's disease and dementia (PDD), 8 patients with Parkinson's disease and normal cognition (PD), and 6 patients with Alzheimer's disease (AD). All AD patients subsequently had the diagnosis proven neuropathologically at autopsy. Correlation coefficients of the metabolic rates across 32 regions of interest were calculated between each pair of patients. Q-component analysis of the correlation matrix showed that the AD and PD groups formed two distinct clusters and that the PDD group had a metabolic pattern which was similar to that of the AD group. Comparison of standardized rCMRG values showed that the PDD group differed from the PD group in having significantly lower relative rCMRG in the left perirolandic and bilateral angular gyrus regions. There were no significant differences between the PDD and AD groups. These results suggest a similar pattern of cortical dysfunction in both Alzheimer's disease and in Parkinson's disease/dementia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2079717     DOI: 10.1002/jnr.490270417

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  6 in total

Review 1.  Functional neuroimaging in Parkinson's disease.

Authors:  Martin Niethammer; Andrew Feigin; David Eidelberg
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

2.  Regional cerebral glucose metabolism in patients with Parkinson's disease with or without dementia.

Authors:  M Sasaki; Y Ichiya; S Hosokawa; M Otsuka; Y Kuwabara; T Fukumura; M Kato; I Goto; K Masuda
Journal:  Ann Nucl Med       Date:  1992-11       Impact factor: 2.668

3.  Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia.

Authors:  Paul Edison; Imtiaz Ahmed; Zhen Fan; Rainer Hinz; Giorgio Gelosa; K Ray Chaudhuri; Zuzana Walker; Federico E Turkheimer; David J Brooks
Journal:  Neuropsychopharmacology       Date:  2012-12-06       Impact factor: 7.853

4.  Benzoyl chloride derivatization with liquid chromatography-mass spectrometry for targeted metabolomics of neurochemicals in biological samples.

Authors:  Jenny-Marie T Wong; Paige A Malec; Omar S Mabrouk; Jennifer Ro; Monica Dus; Robert T Kennedy
Journal:  J Chromatogr A       Date:  2016-04-04       Impact factor: 4.601

Review 5.  Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.

Authors:  Gerwyn Morris; Michael Berk; Ken Walder; Michael Maes
Journal:  BMC Med       Date:  2015-02-06       Impact factor: 8.775

6.  Glucose deprivation increases tau phosphorylation via P38 mitogen-activated protein kinase.

Authors:  Elisabetta Lauretti; Domenico Praticò
Journal:  Aging Cell       Date:  2015-07-29       Impact factor: 9.304

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.